Critical role for monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity

Background

Antibodies (Abs) that mediate antibody-dependent cellular cytotoxicity (ADCC) activity against HIV-1 are of major interest. Considerable evidence supports a role for ADCC activity in the control of HIV-1 infection and in the context of vaccination. One method widely used to assess the role of ADCC is the rapid and fluorometric antibody-dependent cellular cytotoxicity (RFADCC) assay. In the RFADCC assay specific killing of target cells by PBMC is assessed by loss of intracellular CFSE but retention of membrane dye PKH26 (CFSE-PKH26+), which is assumed to be derived from CFSE+PKH26+ target cells killed by NK cells. We have revisited this assay to assess the role of effector cells in mediating ADCC.

Results

Backgating analysis and phenotyping of CFSE-PKH26+ cells identified CD3-CD14+ monocytes as the major effector cell type. This was confirmed for all 57 HIV+ plasma samples tested. Emergence of the CFSE-PKH26+ cell population was observed following co-culture with purified monocytes but not purified NK cells. No significant IFNγ production or CD107a degranulation was detected in NK cells in this assay. Image flow cytometry and microscopy confirmed a monocyte-specific interaction with target cells. Monocytes acquire PKH26+ cell membrane presumably derived from killed target cells without typical morphological changes associated with phagocytosis, suggesting monocyte-mediated ADCC.

Conclusion

Our studies advance the understanding of the cellular events underlying HIV-specific ADCC. The RFADCC assay primarily reflects Ab-mediated monocyte function and has to be treated with caution in regard to NK cell-mediated ADCC. Further studies on the biological importance of HIV-specific monocyte-mediated ADCC are warranted.

Search for R De Rose in:

Search for R Center in:

Search for A Jawarowski in:

Search for S Kent in:

Corresponding author

Correspondence to
M Kramski.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.